Genetic Technologies Ltd/ US37185R4065 /
2024-03-28 8:57:25 PM | Chg. +0.0800 | Volume | Bid10:14:25 PM | Ask10:14:25 PM | High | Low |
---|---|---|---|---|---|---|
2.8900USD | +2.85% | 15,768 Turnover: 40,869.5900 |
2.8700Bid Size: 100 | 2.8900Ask Size: 2,700 | 2.9400 | 2.8000 |
GlobeNewswire
9:51 PM
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
9:32 PM
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
GlobeNewswire
9:30 PM
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatmen...
GlobeNewswire
2:00 PM
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
GlobeNewswire
2:00 PM
New Zealand Mānuka Honey: Science Confirms Genetic Uniqueness And Urges Informed Choices For Consume...
GlobeNewswire
1:00 PM
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cy...
GlobeNewswire
03-26
Gattaca Genomics Partners with Ibanera to Revolutionize Digital Banking for Family Planning Innovati...
GlobeNewswire
03-26
Beam Therapeutics Announces Clearance of Clinical Trial Authorisation Application for BEAM-302 for t...
GlobeNewswire
03-25
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcar...
GlobeNewswire
03-25
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the ...
GlobeNewswire
03-22
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Newsfile Corp
03-22
Jamie Metzl to Speak on AI, Genetics, and Biotechnology Revolutions at the Global AI Show
GlobeNewswire
03-22
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Earl...
GlobeNewswire
03-21
USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred i...
GlobeNewswire
03-21
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a...
GlobeNewswire
03-21
Eisbach and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Phase 1/2 T...